Streetbeat News

Products Services

MSTR

Michael Saylor, a prominent Bitcoin advocate, suggested at the Crypto Summit that the US should acquire 5% to 25% of the total Bitcoin supply. This proposal has sparked debate in both the crypto community and traditional finance.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

EVMOSUSD

The Interchain Foundation has open-sourced Evmos, now rebranded as Cosmos EVM, to integrate EVM compatibility into the Cosmos SDK. This move aims to enhance cross-chain communication between Ethereum and Cosmos, empowering developers with Ethereum features and ERC-20 token integration.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

SHIBUSD

Shiba Inu's Shibarium has achieved a significant milestone, indicating a resurgence in activity after a period of lower engagement.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

GENK

GEN Korean BBQ is expanding its presence in Texas by opening a new location in Austin, following its success in other parts of the state.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

BGM

BGM Group Ltd. has announced the acquisition of YX Management Company Ltd. to enhance its AI strategy for its intelligent platform.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

VZ

Verizon has been recognized as a Leader in the Gartner Magic Quadrant for Managed IoT Connectivity Services, highlighting its strong vision and execution capabilities in the IoT sector.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

DJT

ROKU

Trump Media and Technology Group Corp. has launched the Truth+ streaming app on Roku TVs, expanding its streaming platform's accessibility.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

GTLL

Turbo Energy is expanding its global presence by launching a new business line, Turbo Energy Solutions, in Latin America. The company introduces an Energy-as-a-Service (EaaS) financing model in Chile to help customers mitigate large initial investments in sustainable energy technologies.

Portfolio Pulse from

March 19, 2025 | 12:45 pm

ATNM

Actinium Pharmaceuticals is set to host an investor call to discuss its clinical programs and market opportunities for Actimab-A and Iomab-ACT. The company aims to highlight multi-billion-dollar market opportunities in myeloid malignancies, solid tumors, and cell & gene therapy conditioning. Key clinical data is expected in the second half of 2025.

Portfolio Pulse from

March 19, 2025 | 12:45 pm